Registration
IMPACT HEALTH POLICY PARTNERS for SUMITOMO PHARMA AMERICA, INC.
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to Medicare Part D reform, mental health, central nervous system disorders, and Parkinsons Disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY WYNNE New | Health Policy Counsel, Senate Finance Committee |
Medicare/Medicaid MMM
Issues relating to Medicare Part D reform, mental health, central nervous system disorders, and Parkinsons Disease.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILLY WYNNE New | Health Policy Counsel, Senate Finance Committee |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SUMITOMO DAINIPPON PHARMA CO., LTD. | Japan | Japan | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.